Analisis Efektifitas Biaya Terapi Pengobatan Pasien Diabetes Mellitus Tipe 2 terhadap Kontrol Glukosa Darah
Downloads
Downloads
Indonesia KKR. Infodatin-2020-Diabetes-Melitus.pdf. In.
Dinkes Kota Surabaya. Profil Kesehatan Kota Surabaya 2019. Vol. 4, Buku. 2557. 88–100 p.
Maharrani A. BPJS Kesehatan keluar Rp6,1 triliun untuk tangani diabetes [Internet]. [cited 2023 Jan 10]. Available from: https://www.manajemen-pembiayaankesehatan.net/index.php/berita-nasional/2787-bpjs-kesehatan-keluar-rp6-1-triliun-untuk-tangani-diabetes
Kemenkes RI. Hasil Riset Kesehatan Dasar Tahun 2018. Kementrian Kesehat RI. 2018;53(9):1689–99.
Soelistijo S, Lindarto D, Decroli E, Permana H, Sucipto K, Kusnadi Y et al. Pengelolaan Dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia. Perkeni. 2019. 133 p.
GINA. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2015. (2015). PB PERKENI. Glob Initiat Asthma [Internet]. 2020;46. Available from: www.ginasthma.org.
Priyadi A, Permana H, Muhtadi A, Sumiwi SA, Sinuraya RK, Suwantika AA. Cost-effectiveness analysis of type 2 diabetes mellitus (T2dm) treatment in patients with complications of kidney and peripheral vascular diseases in Indonesia. Healthc. 2021;9(2):1–9.
Banerji MA, Dunn JD. Impact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: Current and future pharmacologic approaches to improving outcomes. Am Heal Drug Benefits. 2013;6(7):382–92.
Yuswantina R, Dyahariesti N. Analisis Efektivitas Biaya Penggunaan Antidiabetes Oral Tunggal dan Kombinasi Pada Pasien BPJS Penderita Diabetes Melitus Tipe 2 di Rumah Sakit X. Media Farm Indones [Internet]. 2018;13(1):1340–6. Available from: https://stifar.ac.id/ojs/index.php/MFI/article/view/47
Gonçalves ACO, Cazarim MDS, Sanches C, Pereira LRL, Camargos AMT, Aquino JA, et al. Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2019;7(1).
Baroroh F, Solikah WY, Urfiyya QA. Analisis Biaya Terapi Diabetes Melitus Tipe 2 di Rumah Sakit PKU Muhammadiyah Bantul Yogyakarta. J Farm Sains dan Prakt [Internet]. 2016;I(2):11–22. Available from: https://journal.unimma.ac.id/index.php/pharmacy/article/download/230/168/
Gray A, Turner R, Raikou M, McGuire A, Fenn P, Stevens R, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: Economic analysis alongside randomised controlled trial (UKPDS 41). Br Med J. 2000;320(7246):1373–8.
Mounié M, Costa N, Gourdy P, Latorre C, Schirr-Bonnans S, Lagarrigue JM, et al. Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Study. Diabetes Ther. 2022;13(4):693–708.
Lilyawati SA, Fitriani N, Prasetya F. Proceeding of Mulawarman Pharmaceuticals Conferences. Proceeding Mulawarman Pharm Conf [Internet]. 2019;(April 2021):135–8. Available from: http://prosiding.farmasi.unmul.ac.id/index.php/mpc/article/view/416/399
Achmad A. Kejadian Efek Samping Potensial Terapi Obat Anti Diabetes Pada Pasien Diabetes Melitus Berdasarkan Algoritme Naranjo. Pharm J Indones. 2017;2(2):45–50.
Diabetes N, Initiative E. 2015 American Diabetes Association ( ADA ) Diabetes Guidelines Summary Recommendations from NDEI 1 . Diabetes Diagnosis. 2015;
Isnani N, Muliyani M, Zaini M, Arif Riyadi M. Analisis Efektivitas Biaya (Cost-Effectiveness) Penggunaan Antidiabetes Oral Kombinasi Pada Pasien Diabetes Melitus Tipe II Rawat Jalan Di Rsud Dr. H. Moch. Ansari Saleh Banjarmasin. J Insa Farm Indones. 2021;4(1):103–10.
Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, et al. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management. Front Endocrinol (Lausanne). 2017;8(January).
Laelasari E, Sauriasari R, Banun A. Cost-effectiveness analysis of insulin, sulfonylurea, and sulfonylurea– Metformin in type 2 diabetes mellitus. Asian J Pharm Clin Res. 2017;10(Special Issue October):50–3.
